European regulators grant marketing authorization to Bydureon, a collaboration between Alkermes...

|About: Alkermes plc (ALKS)|By:, SA News Editor

European regulators grant marketing authorization to Bydureon, a collaboration between Alkermes (ALKS), Eli Lilly (LLY) and Amylin (AMLN) for the treatment of type 2 diabetes. (PR)